Literature DB >> 32804151

Potentially Pathogenic Calcium Oxalate Dihydrate and Titanium Dioxide Crystals in the Alzheimer's Disease Entorhinal Cortex.

Adam Heller1, Sheryl S Coffman1, Karalee Jarvis2.   

Abstract

Knowing that Alzheimer's disease (AD) nucleates in the entorhinal cortex (EC), samples of 12 EC specimens were probed for crystals by a protocol detecting fewer than 1/5000th of those present. Of the 61 crystals found, 31 were expected and 30 were novel. Twenty-one crystals of iron oxides and 10 atherosclerosis-associated calcium pyrophosphate dihydrate crystals were expected and found. The 30 unexpected crystals were NLRP3-inflammasome activating calcium oxalate dihydrate (12) and titanium dioxide (18). Their unusual distribution raises the possibility that some were of AD origination sites.

Entities:  

Keywords:  Alzheimer’s disease pathogenesis; calcium oxalate dihydrate; inflammasome zzm321990activating crystals; titanium dioxide

Year:  2020        PMID: 32804151      PMCID: PMC7592648          DOI: 10.3233/JAD-200535

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


Alzheimer’s disease (AD) nucleates in a small volume-element of the entorhinal cortex (EC) [1, 2], spreads in the EC, expands to the hippocampus then to other parts of the cortex. AD’s hallmark aggregated amyloid-β (Aβ) peptide and hyperphosphorylated tau protein are established propagators of AD, but it is not known if they are its cause. Their presence at the EC initiation-point has not been established. The initiation-point could be microbial [3], cholesterol comprising [4, 5], or as will be discussed below, it could comprise pathogenic crystals. Macrophage [6] and microglial NLRP3 [7-10] and NLRP1 [11, 12] inflammasomes assemble upon phagocytosis of species having certain molecular patterns. The patterns include those of aggregated Aβ42 [7, 8], of aggregated hyperphosphorylated tau [10, 13, 14], of pathogens or their fragments [13, 15], and of biogenic and exogenous crystals. The family of inflammasome-activating biogenic crystals includes sodium urate [16-18], cholesterol [19, 20], calcium oxalate dihydrate (COD) [17, 18], calcium pyrophosphate dihydrate (CPPD) [16, 17], and cystine [17]. The family of exogenous crystals includes quartz [21-23], asbestos [21], titanium dioxide (TiO2) [18, 23], and sintered indium tin oxide [24]. Activation of the NLRP3 inflammasome initiates release of IL-1β and other inflammatory cytokines and induces, through a multistep process, pyroptosis, the death of proximal cells. Upon death of proximal neurons more aggregating Aβ and hyperphosphorylated tau are released and more neurons and synapses perish [10]. The commonality of microbial patterns [13, 15], cholesterol [19, 20], Aβ aggregates [7, 25], and hyperphosphorylated tau aggregates [10] is that all activate the NLRP3 inflammasome. In light of this commonality, we ask here if there are NLRP3 inflammasome-activating crystals in postmortem EC specimens of AD donors [17, 18] that could also be among the point-initiators of AD. Duplicate 200 mg samples of 12 formalin-fixed entorhinal cortex specimens, provided by the NIH Harvard Neurobiobank, were probed. Six of the specimens were of Braak and Braak stages I or II [1] and 6 were of stage V [1]. The samples were homogenized with 1 mL of an aqueous solution containing 40 mg of Proteinase K from Tritirachium album (Sigma P2308). Instead of using the usual crystalline zirconia beads that would have introduced zirconia crystals, the samples were homogenized using 3 mm-diameter non-crystalline Pyrex glass beads. After overnight proteolysis at ambient temperature, the fluid was centrifuged at 13,000 G for 1 h, the supernatant was discarded, and the centrifugate was re-suspended in 0.5 mL de-ionized water and re-centrifuged for 1 h. To strip the water-soluble salts that would have crystallized upon evaporation of the water, the centrifugate was re-suspended in 0.5 mL water, centrifuged at 13,000 G for 10 min, and the supernatant liquid was discarded. The washing-centrifugation cycle was repeated four times, then the final centrifugate was suspended in 0.5 mL water. Five μL of the suspension was withdrawn from the bottom of the vial and applied to a 3 mm diameter, 314 squares, 200 mesh carbon type-B transmission electron microscopy grid support (Ted Pella, Redding CA). The crystals were observed on duplicate grids from duplicate EC samples, i.e., in 2×5 = 10μL, applied to each grid-pair. The grid-pairs were TEM scanned for presence of crystals, then 5 squares of the grid-pair were probed. Because 10μL of the 0.5 mL processed volume was applied to the 2×314 = 628 squares, and because only 5 squares were probed, fewer than 0.015% of the present crystals were detected; furthermore, because the 2×200 mg samples comprised less than 1/5th of the entorhinal cortices, each detected crystal signaled the presence of more than 25,000. Each detected crystal was TEM-imaged; after confirmation of its crystallinity by its electron diffraction pattern, the crystal’s approximate (±5 atom %) elemental composition was determined by energy-dispersive X-ray spectroscopy. Oxygen-assays of those crystals that rapidly lost their water of hydration in the vacuum of the TEM chamber were less accurate; and with the TEM grids being of carbon, and with tissue-residue adhering to the crystals, their carbon was not assayed. If cholesterol crystals were present, these would not have been observed because their 1.05 g cm–3 density prevents their separation by centrifugation. Tables 1 and 2 list the 61 detected crystals: Table 1 listing those that we expected and Table 2 listing those that surprised us. We expected the iron oxide crystals, including the 16 ferrihydrite crystals dehydrating in the TEM’s vacuum chamber to crystalline goethite (Supplementary Figure 1, top left), and the 5 magnetite crystals, from earlier studies of crystals in the AD cortex [26-28]. The crystalline oxides of iron have not been reported to activate the NLRP3 inflammasome. The 10 CPPD crystals, dehydrating in the TEM’s vacuum chamber to calcium pyrophosphate, did not surprise us, because the NIH Harvard Neurobiobank histopathology reports of their donor brains included atherosclerotic plaques [29]. We note, nevertheless, that CPPD is inflammasome-activating [16].
Table 1

Anticipated and found crystals in the AD entorhinal cortex

EC SpecimenAD StageFerrihydrite/GoethiteMagnetiteCPPD
8191I020
9232I100
9078I103
6675I413
1202II010
17142II003
2818V100
0275V100
13857V211
9540V100
8818V000
3273V500
Total16510
Table 2

Novel inflammasome-activating crystals in the AD entorhinal cortex

DonorAgeAD StageCODTiO2
819165I00
923258I10
907860I10
667566I13
120274II10
1714283II01
281873V00
27574V21
1385762V03
954086V03
881885V60
327385V07
Total1218
Anticipated and found crystals in the AD entorhinal cortex Novel inflammasome-activating crystals in the AD entorhinal cortex The 30 unanticipated crystals are listed in Table 2. Twelve were COD crystals of 0.8×0.5μm average imaged area (Supplementary Figure 1, top right) and 18 were TiO2 crystals of 0.3×0.2μm averaged imaged area (Supplementary Figure 1, bottom). The 30 crystals were unevenly distributed between the early and the advanced stage AD specimens, with 22 in the 6 specimens of stage V, and 8 in the 6 specimens of stages I or II. Specimen 8818 of stage V contained half of all the 12 COD crystals and specimen 3273, also of stage V, contained 7 of the 18 TiO2 crystals. The COD crystals lost their water of hydration, fracturing, but remaining crystalline in the vacuum of the TEM chamber, then decomposing under the electron beam to crytalline calcium carbonate and finally to crystalline calcium oxide, CaC2O4.2H2OCaC2O4 + 2H2O↑ ⟶ CaCO3 + CO↑ ⟶ CaO+CO2 ↑. Correspondingly, the Ca/O atom ratio increased from 1 : 6 to 1 : 4, then from 1 : 4 to 1 : 3, then from 1 : 3 to 1 : 1. Phagocytized COD crystals are residents of chronic sterile inflammations of the kidneys and of the cyst [30]. They are found also in the brain after xylitol administration [31], after ethylene glycol (antifreeze) poisoning [32], and in hyperoxaluria [33]. We also found these in the substantia nigra of Parkinson’s disease donors [34]. COD precipitates when the [Ca2 +][oxalate] product-defined solubility-limit is exceeded, i.e., when the Ca2 + concentration is high, when the oxalate concentration is high, or when both are higher than normal. Because exaggerated endothelial reticulum Ca2 + release, leading to elevation of neuronal cytosolic Ca2 + concentration, precedes in the mouse model aggregation of Aβ42 [35], the precipitation of inflammasome-activating COD crystals is not likely to be a result of AD, and can be one of its causes. In the absence of xylitol or ethylene glycol poisoning the oxalate precursors in the CNS is ascorbate [36]. The neuronal concentration of ascorbate is as high as 10 mM [37], twice that of glucose; and the concentration of ascorbate in stimulated macrophages is massive [38], making it likely that it is similarly massive in stimulated microglia. Excessive ascorbate concentration is a recognized cause of sterile inflammatory COD disease [39]. The TiO2 particles of the observed size constitute the white pigment of walls. Smaller TiO2 particles, constituting the white pigment of medications, foods, and cosmetics, were found in the pancreas of obese type 2 diabetic donors [40], their number density scaling with obesity [41]. In conclusion, our study suggests that entorhinal cortex COD and TiO2 crystals should be added to the existing list of potential AD initiators, all known to activate the NLRP3 inflammasome. Click here for additional data file.
  41 in total

1.  Association of Type 2 Diabetes with Submicron Titanium Dioxide Crystals in the Pancreas.

Authors:  Adam Heller; Karalee Jarvis; Sheryl S Coffman
Journal:  Chem Res Toxicol       Date:  2018-06-05       Impact factor: 3.739

Review 2.  Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities.

Authors:  Jin-Tai Yu; Raymond Chuen-Chung Chang; Lan Tan
Journal:  Prog Neurobiol       Date:  2009-08-05       Impact factor: 11.685

Review 3.  Coronary artery calcification: From crystal to plaque rupture.

Authors:  Loïc Panh; Olivier Lairez; Jean-Bernard Ruidavets; Michel Galinier; Didier Carrié; Jean Ferrières
Journal:  Arch Cardiovasc Dis       Date:  2017-07-20       Impact factor: 2.340

Review 4.  The Role of Neuronal NLRP1 Inflammasome in Alzheimer's Disease: Bringing Neurons into the Neuroinflammation Game.

Authors:  Jeremy Kean Yi Yap; Benjamin Simon Pickard; Elaine Wan Ling Chan; Sook Yee Gan
Journal:  Mol Neurobiol       Date:  2019-05-20       Impact factor: 5.590

5.  Crystals in the Substantia Nigra.

Authors:  Adam Heller; Sheryl S Coffman
Journal:  ACS Chem Neurosci       Date:  2019-07-05       Impact factor: 4.418

6.  Crystals in brain and meninges in primary hyperoxaluria and oxalosis.

Authors:  M T Haqqani
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

7.  The NALP3 inflammasome is involved in the innate immune response to amyloid-beta.

Authors:  Annett Halle; Veit Hornung; Gabor C Petzold; Cameron R Stewart; Brian G Monks; Thomas Reinheckel; Katherine A Fitzgerald; Eicke Latz; Kathryn J Moore; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2008-07-11       Impact factor: 25.606

Review 8.  Inflammasome Involvement in Alzheimer's Disease.

Authors:  Ingar Olsen; Sim K Singhrao
Journal:  J Alzheimers Dis       Date:  2016-06-15       Impact factor: 4.472

9.  Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years.

Authors:  P Toro; Ch Degen; M Pierer; D Gustafson; J Schröder; P Schönknecht
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11-17       Impact factor: 5.270

10.  Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis.

Authors:  Shrikant R Mulay; Jyaysi Desai; Santhosh V Kumar; Jonathan N Eberhard; Dana Thomasova; Simone Romoli; Melissa Grigorescu; Onkar P Kulkarni; Bastian Popper; Volker Vielhauer; Gabriele Zuchtriegel; Christoph Reichel; Jan Hinrich Bräsen; Paola Romagnani; Rostyslav Bilyy; Luis E Munoz; Martin Herrmann; Helen Liapis; Stefan Krautwald; Andreas Linkermann; Hans-Joachim Anders
Journal:  Nat Commun       Date:  2016-01-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.